FDA Inspection 772469 — Oklahoma Blood Institute East Central

Oklahoma Blood Institute East Central — FEI 1641495

The FDA completed an inspection of Oklahoma Blood Institute East Central on March 7, 2012 in Ada, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 7, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ada, OK (United States)